Key result
High baseline platelet aggregation to submaximal arachidonic acid predicted aspirin resistance, occurring in 28% of the high aggregation group versus 6% of the low aggregation group.
Why the study?
Does baseline platelet aggregation with submaximal stimulation predict aspirin resistance in healthy subjects?
Observational (n=58)
Does baseline platelet aggregation with submaximal stimulation predict aspirin resistance in healthy subjects?
Platelets in subjects with aspirin resistance demonstrate increased basal sensitivity to submaximal stimulation, which may predict response to antiplatelet therapy.
Answers are grounded in this paper and cite their sources.
May identify aspirin-resistant healthy subjects; hypothesis-generating and requires prospective validation before clinical adoption.
Aspirin 'resistance' (AR) is a phenomenon of uncertain etiology describing decreased platelet inhibition by aspirin. We studied whether (i) platelets in AR demonstrate increased basal sensitivity to a lower degree of stimulation and (ii) platelet aggregation with submaximal stimulation could predict responses to aspirin. Serum thromboxane B(2) (TxB(2)) levels and platelet aggregation with light transmission aggregometry (LTA) were measured at baseline and 24 hours after 325 mg aspirin administration in 58 healthy subjects. AR was defined as the upper sixth of LTA (> or = 12%) to 1.5 mM AA. Baseline platelet aggregation with submaximal concentrations of agonists [ADP 2 microM, arachidonic acid (AA) 0.75 mM, collagen 0.375 and 0.5 microg/ml] was greater in AR subjects compared with non-AR subjects, but not with higher concentrations (ADP 5 microM and 20 microM, AA 1.5 mM and collagen 1 microg/ml). Post-aspirin platelet aggregation was elevated in AR subjects with both submaximal and maximal stimulation. Baseline and post-aspirin serum TxB(2) were higher in AR subjects and decreased further with ex-vivo COX-1 inhibition, suggesting incompletely suppressed COX-1 activity. Pre-aspirin platelet aggregation to 0.75 AA demonstrated a dichotomous response with 29/58 subjects having aggregation < or = 15% and 29/58 subjects having aggregation > or = 75%. In the high aggregation group 28% had AR compared to 6% in the non-AR group (p = 0.04). In conclusion, platelets in AR subjects demonstrate increased basal sensitivity to submaximal stimulation, which could predict responses to antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Guthikonda et al. (2008) conducted an observational in Healthy subjects (n=58). High baseline platelet aggregation to 0.75 mM arachidonic acid vs. Low baseline platelet aggregation was evaluated on Aspirin resistance (p=0.04). High baseline platelet aggregation to submaximal arachidonic acid predicted aspirin resistance, occurring in 28% of the high aggregation group versus 6% of the low aggregation group.
Synapse has enriched 10 related papers. Consider them for comparative context: